Displaying drugs 1401 - 1425 of 1786 in total
L-Xylulose 5-Phosphate
Experimental
4-Hydroxy-Aconitate Ion
Experimental
Fructose -6-Phosphate
Experimental
Zidebactam
Zidebactam is under investigation in clinical trial NCT02674347 (MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults).
Investigational
(3-Formyl-but-3-Enyl)-Phosphonic Acid
Experimental
Guvacine
Guvacine is a pyridine alkaloid found in the Areca nut (also known as the Betel nut). It is an experimental drug with no approved indication. Experimental studies are still being investigated to determine all of the physiological effects and mechanisms of action of guvacine. Currently it has been determined that...
Experimental
1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE
Experimental
1,6-Fructose Diphosphate (Linear Form)
Experimental
Ribulose-5-Phosphate
Experimental
Fructose-6-phosphate
Experimental
Etynodiol
Etynodiol (INN), or ethynodiol (BAN) is a steroidal progestin related to norethisterone which was never marketed. While etynodiol is sometimes used as a synonym for etynodiol diacetate, it usually refers to etynodiol diacetate (see DB00823), not etynodiol.
Experimental
1-Androstenediol
Experimental
Illicit
Isocitric Acid
Experimental
1-Carboxyethylaminomethyl-4-Aminomethylbenzene
Experimental
Pantothenoylaminoethenethiol
Experimental
CHROMOPHORE (ASP-TYR-GLY)
Experimental
Pilsicainide
Pilsicainide has been investigated for the treatment of Paroxysmal Atrial Fibrillation.
Investigational
Retagliptin
Retagliptin is under investigation in clinical trial NCT02822534 (The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients).
Investigational
KC706
KC706 is a novel anti-inflammatory drug that works by inhibiting the activity of p38 MAP kinase. KC706 holds potential to treat inflammatory conditions such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and cardiovascular disease.
Investigational
Displaying drugs 1401 - 1425 of 1786 in total